P32 Sodium Phosphate
Product Images NDC 51808-127

2 FDA label images from Anazaohealth Corporation · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for P32 Sodium Phosphate (NDC 51808-127). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Anazaohealth Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

5ed86373-figure-01 (5ed86373 Figure 01)

5ed86373-figure-01 (5ed86373 Figure 01)
A data table showing decay factors for P32 Sodium Phosphate at various days and decay factor columns numbered 0 to 9. The rows are labeled with days: 0, 10, 20, and 30. The table is used to find decay correction factors for radioactive decay calculations.*
FDA Label Image

5ed86373-figure-02 (5ed86373 Figure 02)

5ed86373-figure-02 (5ed86373 Figure 02)
P32 Sodium Phosphate suspension label for injection, concentration 15 mCi/mL in a 3 mL volume. The label shows additional ingredients including Dextrose, Sodium Acetate, and Benzyl Alcohol. It is marked as pharmacy compounded, sterile, and non-pyrogenic. Labeler is AnazaoHealth Corporation with contact and location details in Tampa, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.